MSAG signature

MSAG signature is associated with poor prognosis in silico.

“This signature successfully distinguishes a senescence-associated, immunosuppressive subtype linked to poor prognosis in pan-cancer cohorts.”

In silicopan-cancer cohorts

Tumor Microenvironment Hijacks and Accelerates a Physiological Myeloid Senescence Signature Associated with Pan-Cancer Immunosuppression and Prognostic Stratification

International journal of molecular sciences·24 Jun 2026